Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Parallel Group Phase III Clinical Study to Evaluate the Efficacy and Safety of X842 Capsules in Patients With Reflux Esophagitis

NCT07079540 is registered in ClinicalTrials.gov with Jiangsu Sinorda Biomedicine Co., Ltd as lead sponsor.

NCT NCT07079540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07079540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Parallel Group Phase III Clinical Study to Evaluate the Efficacy and Safety of X842 Capsules in Patients With Reflux Esophagitis
Lead sponsor
Jiangsu Sinorda Biomedicine Co., Ltd
Phase
Phase 3
Overall status
Completed
Start date
June 24, 2021
Completion date
December 1, 2022
Enrollment
380 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

reflux esophagitis